Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer

被引:263
作者
Ceppi, Paolo [1 ,2 ,3 ]
Mudduluru, Giridhar [1 ,2 ]
Kumarswamy, Regalla [1 ,2 ]
Rapa, Ida [3 ]
Scagliotti, Giorgio V. [3 ]
Papotti, Mauro [3 ]
Allgayer, Heike [1 ,2 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Dept Expt Surg & Mol Oncol Solid Tumors, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
[3] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Orbassano, Italy
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; REPRESSORS ZEB1; STEM-CELLS; U-PAR; FAMILY; METASTASIS; SENSITIVITY; SNAIL; METHYLATION;
D O I
10.1158/1541-7786.MCR-10-0052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of metastases is the main reason for cancer-related death in non-small cell lung cancer (NSCLC). The initiation of metastasis involves an increase in cell motility mediated by the loss of cell-cell adhesion caused by E-cadherin repression, in a process commonly known as epithelial-to-mesenchymal transition. A role for microRNA-200 family members in regulating epithelial-to-mesenchymal transition has recently been indicated but data about their expression in lung tumors is still unavailable. The present study investigated the expression of miR-200c in a panel of NSCLC cell lines (n = 9), and a strong inverse correlation with invasion was detected. Reintroduction of miR-200c into highly invasive/aggressive NSCLC cells induced a loss of the mesenchymal phenotype by restoring E-cadherin and reducing N-cadherin expression, and inhibited in vitro cell invasion as well as in vivo metastasis formation. Moreover, miR-200c overexpression restored the sensitivity of NCI-H1299 cells to cisplatin and cetuximab. Hypermethylation of the promoter region was found to be responsible for the loss of miR-200c in invasive cells, as evaluated by 5-aza-2'-deoxycytidine treatment, methylation-specific PCR, and bisulfite sequencing. In primary tumor specimens obtained from 69 patients with consecutively resected NSCLC, lower miR-200c expression levels were found to be associated with a poor grade of differentiation (P = 0.04), a higher propensity to lymph node metastases (P < 0.01), and with a lower E-cadherin expression (P = 0.01). These data indicate that the loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype, and that assessment of its expression could contribute to a better clinicopathologic definition of patients with NSCLC. Mol Cancer Res; 8(9); 1207-16. (C)2010 AACR.
引用
收藏
页码:1207 / 1216
页数:10
相关论文
共 33 条
[1]   miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [J].
Adam, Liana ;
Zhong, Meng ;
Choi, Woonyoung ;
Qi, Wei ;
Nicoloso, Milena ;
Arora, Ameeta ;
Calin, George ;
Wang, Hua ;
Siefker-Radtke, Arlene ;
McConkey, David ;
Bar-Eli, Menashe ;
Dinney, Colin .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5060-5072
[2]   Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer [J].
Arumugam, Thiruvengadam ;
Ramachandran, Vijaya ;
Fournier, Keith F. ;
Wang, Huamin ;
Marquis, Lauren ;
Abbruzzese, James L. ;
Gallick, Gary E. ;
Logsdon, Craig D. ;
McConkey, David J. ;
Choi, Woonyoung .
CANCER RESEARCH, 2009, 69 (14) :5820-5828
[3]   Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions [J].
Barr, Sharon ;
Thomson, Stuart ;
Buck, Elizabeth ;
Russo, Suzanne ;
Petti, Filippo ;
Sujka-Kwok, Izabela ;
Eyzaguirre, Alexandra ;
Rosenfeld-Franklin, Maryland ;
Gibson, Neil W. ;
Miglarese, Mark ;
Epstein, David ;
Iwata, Kenneth K. ;
Haley, John D. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :685-693
[4]   Pre-EMTing metastasis?: Recapitulation of morphogenetic processes in cancer [J].
Berx, Geert ;
Raspe, Eric ;
Christofori, Gerhard ;
Thiery, Jean Paul ;
Sleeman, Jonathan P. .
CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (08) :587-597
[5]   Correlation of Snail expression with histological grade and lymph node status in breast carcinomas [J].
Blanco, MJ ;
Moreno-Bueno, G ;
Sarrio, D ;
Locascio, A ;
Cano, A ;
Palacios, J ;
Nieto, MA .
ONCOGENE, 2002, 21 (20) :3241-3246
[6]   Everything you wanted to know about small RNA but were afraid to ask [J].
Boyd, Scott D. .
LABORATORY INVESTIGATION, 2008, 88 (06) :569-578
[7]   A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J].
Burk, Ulrike ;
Schubert, Joerg ;
Wellner, Ulrich ;
Schmalhofer, Otto ;
Vincan, Elizabeth ;
Spaderna, Simone ;
Brabletz, Thomas .
EMBO REPORTS, 2008, 9 (06) :582-589
[8]   Gene regulation by microRNAs [J].
Carthew, RW .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (02) :203-208
[9]   Polymerase η mRNA Expression Predicts Survival of Non - Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy [J].
Ceppi, Paolo ;
Novello, Silvia ;
Cambieri, Alberto ;
Longo, Marina ;
Monica, Valentina ;
Lo Iacono, Marco ;
Giaj-Levra, Matteo ;
Saviozzi, Silvia ;
Volante, Marco ;
Papotti, Mauro ;
Scagliotti, Giorgio .
CLINICAL CANCER RESEARCH, 2009, 15 (03) :1039-1045
[10]   MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents [J].
Cochrane, Dawn R. ;
Spoelstra, Nicole S. ;
Howe, Erin N. ;
Nordeen, Steven K. ;
Richer, Jennifer K. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) :1055-1066